Pricing & Access· June 24, 2026 · 26 min read
Roche Genentech Portfolio Dossier: Subcutaneous Biologic Transitions
By Ran Chen#Purple Book#Biosimilars#J-Code
Topic
Step Therapy
Fail-first rules, preferred-drug sequencing, exception pathways, and payer documentation needed before access opens.
Pricing & Access· June 6, 2026 · 14 min read
Aetna GLP-1 coverage: PA criteria, formulary tiers, and 2026 plan rules
By Ran Chen#GLP-1#Aetna#Prior Authorization
Pricing & Access· June 6, 2026 · 13 min read
Anthem BCBS GLP-1 coverage: PA criteria, formulary tiers, and 2026 plan rules
By Ran Chen#GLP-1#Anthem#Blue Cross Blue Shield
Pricing & Access· June 6, 2026 · 11 min read
BCBSTX GLP-1 coverage: formulary rules, PA criteria, and 2026 updates for Texas members
Specialty· June 6, 2026 · 14 min read
GLP-1 insurance coverage checker: verify benefits and PA status
Pricing & Access· June 6, 2026 · 10 min read
GLP-1 PA: BMI thresholds, comorbidity docs, and denial reasons by payer
By Ran Chen#GLP-1#Prior Authorization#BMI
Pricing & Access· June 6, 2026 · 14 min read
GLP-1 reauthorization denial appeal: overturning PA renewal refusals
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage
Specialty· June 6, 2026 · 16 min read
GLP-1 step therapy exception: document contraindication and prior-therapy failure
By Ran Chen#GLP-1#Step Therapy#Prior Authorization
Pricing & Access· June 6, 2026 · 11 min read
Harvard Pilgrim GLP-1 coverage: PA criteria and 2026 formulary rules
By Ran Chen#GLP-1#Harvard Pilgrim#Prior Authorization
Pricing & Access· June 6, 2026 · 14 min read
Kaiser Permanente GLP-1 coverage: CBC criteria, step therapy, 2026
By Ran Chen#GLP-1#Kaiser Permanente#Prior Authorization